Accéder au contenu
Merck

The RNA-Binding Protein A1CF Regulates Hepatic Fructose and Glycerol Metabolism via Alternative RNA Splicing.

Cell reports (2019-10-10)
Kostas C Nikolaou, Hasan Vatandaslar, Cindy Meyer, Marc W Schmid, Thomas Tuschl, Markus Stoffel
RÉSUMÉ

The regulation of hepatic gene expression has been extensively studied at the transcriptional level; however, the control of metabolism through posttranscriptional gene regulation by RNA-binding proteins in physiological and disease states is less understood. Here, we report a major role for the hormone-sensitive RNA-binding protein (RBP) APOBEC1 complementation factor (A1CF) in the generation of hepatocyte-specific and alternatively spliced transcripts. Among these transcripts are isoforms for the dominant and high-affinity fructose-metabolizing ketohexokinase C and glycerol kinase, two key metabolic enzymes that are linked to hepatic gluconeogenesis and found to be markedly reduced upon hepatic ablation of A1cf. Consequently, mice lacking A1CF exhibit improved glucose tolerance and are protected from fructose-induced hyperglycemia, hepatic steatosis, and development of obesity. Our results identify a previously unreported function of A1CF as a regulator of alternative splicing of a subset of genes influencing hepatic glucose production through fructose and glycerol metabolism.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Insuline solution human, sterile-filtered, BioXtra, suitable for cell culture
Sigma-Aldrich
Réactif TRI®, For processing tissues, cells cultured in monolayer or cell pellets
Sigma-Aldrich
Dexaméthasone, powder, BioReagent, suitable for cell culture, ≥97%
Sigma-Aldrich
D-(−)-fructose, ≥99% (HPLC)
Sigma-Aldrich
L-lactate de sodium, ~98%
Sigma-Aldrich
Pyruvate de sodium, ReagentPlus®, ≥99%
Sigma-Aldrich
Schiff′s Reagent
Sigma-Aldrich
4-Thiouridine, ≥98%
Sigma-Aldrich
D-(+)-Glucose, BioUltra, anhydrous, ≥99.5% (sum of enantiomers, HPLC)
Sigma-Aldrich
Glucagon, synthetic, powder, suitable for cell culture
Sigma-Aldrich
MISSION® esiRNA, targeting human HNRNPH2